Overall rank by patents
#28,571
Across all tracked assignees
USPTO 2015–2025 USPTO PatentsView US Corporation
Dance Biopharm Inc.
USPTO PatentsView assignee record - 9 granted patents across 5 technology areas, active 2015–2020. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
9
Total patents granted
5
CPC technology areas
18.4
Avg claims per patent
-71%
5-year filing velocity
The verdict
Dance holds 9 US patents across 5 technology areas, rank #28,571 of 50,000 tracked assignees.
- #28,571
- of 50,000 US assignees by volume
- Top 78%
- by Innovation Score (26.9/100)
- 18.4
- avg claims per patent
- -71%
- filing velocity, last 5 yrs
Portfolio overview
Dance Biopharm Inc. has been granted 9 US utility patents between 2015 and 2020, placing Dance Biopharm Inc. at rank #28,571 across all assignees tracked by PlainPatent. This portfolio spans 5 distinct Cooperative Patent Classification (CPC) subclasses, averaging 18.4 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a US Corporation, Dance Biopharm Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Dance sits between Daedalus Cloud Llc (9 patents, rank #28,567) and Dataguise, Inc. (9 patents, rank #28,575) - the closest US assignees by grant volume. The composite Innovation Score of 26.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 2 grants, compared with 7 in the 2015–2019 window, a -71% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Dance Biopharm Inc.'s 18.4 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 5 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Dance Biopharm Inc. against peers pursuing similar technology classes.
Who files at Dance's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Daedalus Cloud
Daedalus Cloud LLC
9 patents
- Daedalus Prime
Daedalus Prime LLC
9 patents
- Daishowa Seiki
Daishowa Seiki Kabushiki Kaisha
9 patents
- Dali Medical Devi…
Dali Medical Devices Ltd
9 patents
- Data Culpa
Data Culpa, Inc.
9 patents
- Datalocker
DataLocker Inc.
9 patents
- Datatorrent
DataTorrent, Inc.
9 patents
- Dataguise
Dataguise, Inc.
9 patents
- Dance Biopharm ◀
Dance Biopharm Inc.
9 patents
What this shows Dance holds 9 patents at rank #28,571, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Dance
By rank, the assignees closest to #28,571 in granted patent volume.
- Daedalus Cloud Llc #28,567 · 9 patents
- Daedalus Prime Llc #28,568 · 9 patents
- Daishowa Seiki Kabushiki Kaisha #28,569 · 9 patents
- Dali Medical Devices Ltd #28,570 · 9 patents
- Data Culpa, Inc. #28,572 · 9 patents
- Datalocker Inc. #28,573 · 9 patents
- Datatorrent, Inc. #28,574 · 9 patents
- Dataguise, Inc. #28,575 · 9 patents
Leaders in A61M (Devices FOR Introducing Media INTO)
Other assignees with the most granted patents in Dance's primary technology class.
- Becton, Dickinson And Company 1,249 in class
- Sanofi-aventis Deutschland Gmbh 1,159 in class
- Boston Scientific Scimed, Inc. 901 in class
- Koniniklijke Philips N.v. 836 in class
- Fisher & Paykel Healthcare Limited 773 in class
- Covidien Lp 726 in class
- Terumo Kabushiki Kaisha 724 in class
- Resmed Pty Ltd 682 in class
Dance's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
27 Top 78% higher than 22% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 3 | 33.3% |
| 2017 | 1 | 11.1% |
| 2018 | 1 | 11.1% |
| 2019 | 2 | 22.2% |
| 2020 | 2 | 22.2% |
Which technologies does Dance Biopharm Inc. patent most?
Top 5 of 5 technology areas
Patent Moat Analysis
Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Declining
Frequently Asked Questions
How many patents does Dance Biopharm Inc. hold?
Dance Biopharm Inc. holds 9 US granted patents filed between 2015 and 2020, spanning 5 technology areas.
What is Dance Biopharm Inc.'s Innovation Score?
Dance Biopharm Inc. has an Innovation Score of 26.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Dance Biopharm Inc. focus on?
Dance Biopharm Inc.'s top technology area is A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR) with 9 patents. The company has filed patents in 5 CPC subclasses total.
Is Dance Biopharm Inc.'s patent filing rate increasing or decreasing?
Dance Biopharm Inc.'s recent filing velocity is -71% compared to the prior five-year period. Filing activity has slowed relative to earlier years.
What does claim depth mean for Dance Biopharm Inc.'s patents?
Dance Biopharm Inc.'s patents average 18.4 claims each. This falls within the standard range, providing solid legal coverage.
How is the Dance Biopharm Inc. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.
How to use this portfolio
Dance's 9 grants land it in the top 78% by Innovation Score, but volume alone doesn't tell you where the strength sits.
- Read that count against the largest US assignees before treating it as dominance - Dance ranks #28,571 of 50,000. Top 50 holders
- Most of this portfolio concentrates in A61M - see who else leads that technology area. A61M leaders
- Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.